Clinical Trial Update: A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis

View source ↗

Summary

This clinical trial update describes a real-world study of guselkumab in Chinese participants with ulcerative colitis, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Colitis, Ulcerative | Status: RECRUITING